Given the complexity of scientific developments inside and outside the psychoanalytic field, traditional definitions of basic psychoanalytic notions are no longer sufficiently comprehensive. We need conceptualizations that encompass new clinical phenomena observed in present-day patients and that take into account contributions inside, outside, and on the boundaries of our practice. This book discusses theoretical concepts which explain current clinical expressions that are as ineffable as they are commonplace. Our patients resort to these expressions when they feel distressed by their perception of themselves as unreal, empty, fragile, non-existent, non-desiring, doubtful about their identity, beset by feelings of futility and apathy, and emotionally numb. The book aims at contrasting the ideas of Winnicott and Kohut, which are connected with a clinical practice that sees each patient as unique and are moreover in direct contact with empirical facts, and applies them to the benefit of complex patients. These ideas facilitate the expansion of paths in both the theory and the practice of our profession. Uniquely contrasting the works of two seminal thinkers with a Latin American perspective, Winnicott and Kohut on Intersubjectivity and Complex Disorders will be invaluable to clinicians and psychoanalysts.

First published in 1995. Routledge is an imprint of Taylor & Francis, an informa company.

This book, about involuntary commitment proceedings, focuses on interpretive practice at the nexus of legal, psychiatric, and practical reasoning. It describes the interactional dynamics through which legally and psychiatrically warranted decisions are publicly argued, negotiated, and justified.

This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroborating the overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.

Delve into the uncharted territory of the "hidden" drug addict--users who are not in treatment, not incarcerated, and not officially accessible for research purposes through traditional means. AIDS and Community-Based Drug Intervention Programs describes short-term interventions used to reduce the odds that these drug users will get infected by the Human Immunodeficiency Virus (HIV). The book explains new methods that are being developed, such as targeted sampling, social network analysis, geomapping, and other amalgams of both quantitative and qualitative approaches, that need to be forged to overcome the challenges of the war against AIDS. The research described in this important book was conducted under the Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research funding mechanism of the National Institute on Drug Abuse (NIDA). Chapters include research on several ethnic groups, including Alaska natives, Puerto Ricans, and Navaho teens. AIDS and Community-Based Drug Treatment Programs, written by experts in the field, is a broad-based treatment of the subject by those who are actually doing the work in the trenches. Authors cover topics such as: the use of goal-oriented counseling and peer support to reduce HIV/AIDS risk quantitative and qualitative methods to assess behavioral change among injection drug users (IDUs) the importance of sampling from hidden populations in research a public health model for reducing AIDS-related risk behavior among IDUs and their sexual partners characteristics of female sexual partners of IDUs strategies used to implement random sampling strategies in the recruitment of out-of-treatment crack and IDUs ethnographic analysis of intravenous drug use analysis of contact tracing strategies employed to combat the AIDS epidemic the use of pile sorts to enhance other tools used by drug prevention programsAIDS and Community-Based Drug Intervention Programs is full of current research and useful information for professionals interested in learning about strategies for conducting HIV/AIDS research among hard-to-reach populations. Substance abuse researchers, treatment professionals, and people involved in AIDS prevention programs, state and county health departments, and criminal justice systems will find much relevant and important information to use in their daily work.

This volume offers guidelines for managing the therapist-patient relationship during crisis intervention and longer-term therapy with patients who exhibit borderline symptoms. Since to do no harm is the primary goal of any therapist who encounters such a patient, an appropriate therapist-patient relationship is crucial; moreover, skillful management of this relationship can, in itself, be the most effective and safe treatment. The authors present a conceptual model, based on self psychology and interpersonal theory, for reframing the borderline symptoms and the therapist's reactions. Case examples demonstrate effective relationship management and therapeutic interventions.

Related link: Free Email Alerting

Draws on 18 months of the author's fieldwork. Demonstrates how service users can work creatively with the clinical circuitries, biomedical imaginaries and temporal underpinnings of clozapine treatment to personalise their experiences and to exert subtle personal power over their health and future prospects. The first ethnography to examine clozapine treatment in the UK and Australia.

Here is a diverse compilation of current knowledge in public mental health marketing. A balanced collection of both research and how-to chapters, Public Mental Health Marketing helps practitioners and researchers learn to target specific groups more effectively, increasing their marketing effectiveness to benefit both mental health agencies and the people they serve. It presents a cross section of recent research on the many participants in the mental health system, including clients, donors, internal stakeholders, and the general public. Over a dozen chapters focus on the marketing of local, state, and national mental health agencies and their relationships with their various clienteles. This helpful book contains original research, tutorials, and case studies in areas such as the public as a target market, primary and secondary consumers'views of the system, referral and secondary resource markets, adolescents as a prevention and intervention market, and promotional and evaluative tools. Learn about the principles of marketing as they relate to mental health professionals; the use of fear appeals in public service announcements; building a marketing environment in community mental health settings; an analysis of changes in the marketing of mental health products to government, business, and industry; and strategies to identify and reach adolescents at risk for drug and alcohol abuse. Public Mental Health Marketing also contains abstracts for nearly one hundred recent articles and monographs that are useful to researchers and practitioners of marketing in the mental health field. Public information and public relations officers in local, state, and national mental health agencies, and academic and public policy researchers from both the mental health and marketing disciplines will find the information they need to increase the effectiveness of their work.

Because chronic disorder is becoming an ordinary feature of family life and development, understanding its impact has become critical. This volume, and the conference proceedings it reports, represents a major effort to examine the family's response to chronic physical or psychopathological illness in one or more of its members. Recent data are revising our notions of chronic illness. Evidence is mounting that chronic psychiatric disorders reflect, in part, abnormalities of brain structure and function. In this sense, they are, in part, medical disorders. On the other hand, a number of traditionally labeled medical disorders produce a broad range of psychological symptoms and are exquisitely sensitive to psychosocial influences.
Families undergo a complex process of adaptation during which their response to stress and their fundamental beliefs about learning and parenting change. These beliefs endure and are difficult to alter. By examining the processes in a wide range of chronic conditions, this volume helps to identify the common, underlying processes of adaptation. The first three chapters concern the families' responses to disorders that are distinctly medical; the next three focus on families' responses to "grey zone" disorders or anomalies that appear early in life, minor physical anomalies, and communication handicaps; and one chapter focuses exclusively on schizophrenia. The last chapter reflects an effort to develop a model based on the experience of researchers with both psychiatric and medical illness.

This book presents state-of-the-art information on both the scientific and clinical aspects of the Millon Clinical Multiaxial Inventory, a test that uniquely assesses both personality pathology and psychopathology. The book presents original contributions from major researchers/clinicians who have published seminal papers on the MCMI and who are recognized authorities in their specific areas. Clinical examples of the MCMI with a variety of clinical populations are provided, and many chapters summarize the research in that area as well as present clinical illustrations of the MCMI with actual cases.
The book provides the reader with the most accurate information on the MCMI -- a test that has made exciting advances in the assessment of personality and psychopathology. The scientific and clinical status of this instrument is presented with a variety of clinical populations, including major psychiatric disorders, depression, substance abuse, anxiety disorders, eating and stress disorders, etc. Recent applications and advances in special areas, such as the instrument's use with medical populations and non-clinical populations, are also presented.

Betty Berzon, renowned psychotherapist and author of the bestselling book "Permanent Partners," tells her own incredible story here. Berzon's journey from psychiatric patient on suicide watch--her wrists tethered to the bed rails in a locked hospital ward--to her present role as a groundbreaking therapist and gay pioneer makes for purely compelling reading.
Berzon is recognized today as a trailblazing co-founder of a number of important lesbian and gay organizations and one of the first therapists to focus on means of developing healthy gay relationships and overcoming homophobia. Her sometimes bumpy road to success never fails to fascinate. Along the way she encounters such luminaries as Anais Nin, Eleanor Roosevelt, the Sitwells, Evelyn Hooker, and Paul Monette. Her recollections here provide a collective portrait of her fellow pioneers and a stirring lesson in twentieth-century history.
It is, however, the intimate story of Berzon's own private passage toward self-discovery--from mental breakdown and suicide attempts, through hospitalization, eventual triumphant recovery, and her own coming out as an open lesbian at the age of forty--that makes this memoir an urgent, insightful, and deeply emotional testament to human survival.

The second edition of this successful handbook, edited by well-known experts in this field, includes core questions in the field of child abuse and neglect. It addresses major challenges in child maltreatment work, starting with "What is child abuse and neglect?" and then examines why maltreatment occurs and what are its consequences. The handbook also addresses prevention, intervention, investigation, treatment as well as civil and criminal legal perspectives. It comprehensively studies the issue from the perspective of a broader, international and cross-cultural human experience. Apart from a thorough revision of existing chapters, this edition includes many new chapters covering recent developments in this area and other issues not covered in the first edition. There is more focus on substance abuse, psychological abuse, and on social and community involvement and public health provisions in the prevention of child maltreatment. The handbook examines what is known now and more importantly what remains to be researched in the coming decades to help abused and neglected children, their families and their communities, thereby taking the field forward.

First published in 1992. Part I of the book covers phases of treatment for specific phases of recovery by describing key concepts and focusing on three dominant treatment modalities, inpatient, outpatient, and long-term residential therapeutic communities. Part II covers, in substantial depth, psychoanalytic/psychodynamic approaches. art III of the book examines cognitive-behavioral, self-help, and relapse prevention approaches to the treatment of the chemically dependent. Part VI mentions in all phases of treatment and recovery. Part IV of the book provides an overview of contemporary trends in research, while also discussing implications for treatment. n the therapeutic community. Part V attempts to draw the field of chemical dependency toward recognition of the importance of considering distinct population characteristics and how these characteristics may dictate modifications in treatment design. The book is suitable as a text in a course on substance abuse or as a critical reference for anyone doing clinical work or research in the field of chemical dependency.

When it was first published in 1980, the Diagnostic and Statistical Manual of Mental Disorders, Third Edition--univer-sally known as DSM-III--embodied a radical new method for identifying psychiatric illness. Kirk and Kutchins challenge the general understanding about the research data and the pro-cess that led to the peer acceptance of DSM-III. Their original and controversial reconstruction of that moment concen-trates on how a small group of researchers interpreted their findings about a specific problem--psychiatric reliability--to promote their beliefs about mental illness and to challenge the then-dominant Freudian paradigm.

Adolescent Stress concentrates on a range of major problems-those of a normal developmental nature as well as those of poor adaptation-identified in adolescents.

This volume reflects the achievements in developing new concepts and models of family therapy and new approaches to special clinical issues and problems during the 1980s. Chapters by experts such as Boszormenyi-Nagy, Everett, Guttman, Lankton, Liddle, McGoldrick, Madanes, and Walsh offer insight into a variety of areas including systems theory, cybernetics, and epistemology; contextual therapy; Ericksonian therapy; strategic family therapy; treating divorce in family therapy practice; ethnicity and family therapy; and training and supervision in family therapy.

Related link: Free Email Alerting

Related link: Free Email Alerting
eBook available with sample pages: 0203405978

Handbook of Effective Psydwtherapy is the culmination of 15 years of personal interest in the area of psychotherapy outcome research. In my view, this is one of the most interesting and crucial areas in the field: it has relevance across disparate clinical disciplines and orientations; it provides a measure of how far the field has progressed in its efforts to improve the effectiveness of psychotherapeutic inter vention; and it provides an ongoing measure of how readily clinicians adapt to scientific indications in state-of-the-art care. Regrettably, as several of the chapters in this volume indicate, there is a vast chasm between what is known about the best available treatments and what is applied as the usual standard of care. On the most basic level there appears to be a significant number of clinicians who remain reluctant to acknowledge that scien tific study can add to their ability to aid the emotionally distressed. I hope that this handbook, with its many delineations of empirically supported treatments, will do something to remedy this state of affairs."

Using actual case material from the psychiatric hospital setting, the principal setting in which psychological assessments are conducted, this volume shows how psychological assessment contributes to the clarification of diagnostic issues and the development of an optimal treatment plan. Beginning with disorders usually first evident in infancy, childhood, or adolescence and ending with the Axis II personality disorders, the book presents an array of case material to reflect the range of DSM-III-R categories. Few changes have been made in the original test materials provided or in the clinical situations presented. The authors examine the relationship between the psychological assessments implemented by clinical psychologists and the treatment planning situation faced by the provider of clinical services. This volume should be a valuable resource for psychologists, psychiatrists, nurses, social workers, counsellors, and other mental health professionals.

Here is a thoughtful new book for professionals who assist persons afflicted with neuromuscular disorders to help them and their families adapt to lifestyle changes accompanying the onset of these disorders. Health care professionals provide strategies to maintain the psychosocial well-being of children and adults with neuromuscular disorders which, in addition to physical damage, also assault the sense of self and challenge the individual's ability to move and communicate. Chapters describe the psychosocial aspects of a variety of neuromuscular diseases such as Duchenne and myotonic muscular dystrophy, multiple sclerosis, amyotrophic lateral sclerosis, Friedeich's ataxia, and Charcot-Marie-Tooth disease. The distinctive characteristics of each disease are examined with special attention given to the natural history, treatment, management, and psychosocial issues of the specific disorder. Beyond the clinical and research importance of Muscular Dystrophy and Other Neuromuscular Diseases, it also addresses the anxiety, doubts, and questions felt by patients with chronic progressive disabilities and their families. This helpful guide is unique in the way it features the interaction of professionals in the social services, psychology, religion, and various medical specialties in the care and treatment of these patients. Professionals in all of these disciplines, as well as the patients and families afflicted by these disorders, will benefit from this valuable resource.

Highlighting the current developments and future directions in GABA and glycine research, this volume covers the major inhibitory neurotransmitters from the molecular mechanisms of signal transduction to their role in health and disease. It is of topical importance because these neurotransmitters are essential for brain function and therapy of diseases such as anxiety disorders, insomnias, epilepsy, depression, spasticity, and memory deficits. Distinguished scientists at the forefront of research contributed reviews on the role of these transmitters in governing neuronal networks, their signalling pathways, their receptors, the pharmacology of GABA A- and GABA B- and GABA C-receptors as well as of GABA- and glycine-transporters, and their role in disease. The volume serves as reference for pharmacologists/toxicologists, neuroscientists, neurologists and psychiatrists.

Psychiatric Pharmacogenomics is a book written to help clinicians to use pharmacogenomic testing to improve the pharmacotherapy that they provide for their patients. It is designed to teach clinicians how to order pharmacogenomic tests and interpret the results. Clinical examples are used to underscore the specific indications for pharmacogenomic testing and to clarify the clinical usefulness of identifying atypical genotypes that result in problematic responses to medication.
The first section of the book begins with a basic review of molecular genetics. Additionally, the book also includes an extensive glossary of technical terms associated with molecular genetics and pharmacogenomics. The clinical utility of pharmacogenomic testing is demonstrated throughout the book by describing the implications of genetic variations for the care of individual patients.
The second section of the book is organized into fourteen chapters that each focus on the clinical implications of testing for specific genes for which variants have been associated with either therapeutic response or side effects of psychotropic medications. Each of these chapters is structured in the same manner and involves a description of the gene and its significant variants. Each chapter also includes one or more clinical vignettes.
The third section of the book discusses the clinical usefulness of pharmacogenomic testing, ethical issues associated with pharmacogenomic testing, and provides predictions for the future development of more sophisticated pharmacogenomic testing.

AIDS and the virus that causes it have challenged the world's scientists, health care systems, and public health policies as much or more than any medical problem in recorded history. Perhaps this is so because this particular infirmity constitutes more than a merely medical problem: it is enmeshed in psychological, social, cultural, political, and economic contexts. This book examines the need for pragmatic and research-based suggestions on how to address some important problems related to these contexts. Although much basic research in virology and immunology can be accomplished within the biomedical domain, biobehavioral disciplines such as behavioral medicine offer more opportunities for the comprehensive approach necessary to confront the AIDS/HIV problem. The editors of this groundbreaking volume suggest that the very nature of this constantly evolving problem encourages an approach to research and intervention/prevention efforts that emphasizes flexibility of response to changing knowledge, patterns of the pandemic, new treatments, and shifts in public opinion and behavior. A major triumph in dealing with this phenomenon would include a bridging of the gap between research and applied efforts, which has been the largest obstacle for progress to date. In this book, such previously uncharted territory is explored, opening a host of new possibilities for dealing with the very real threat of AIDS.